0.372
Schlusskurs vom Vortag:
$0.383
Offen:
$0.3737
24-Stunden-Volumen:
158.76K
Relative Volume:
0.09
Marktkapitalisierung:
$32.76M
Einnahmen:
$8.97M
Nettoeinkommen (Verlust:
$-5.72M
KGV:
-5.3067
EPS:
-0.0701
Netto-Cashflow:
$-2.93M
1W Leistung:
+8.82%
1M Leistung:
+17.45%
6M Leistung:
+24.66%
1J Leistung:
-62.05%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Firmenname
Milestone Scientific Inc.
Sektor
Telefon
973-535-2717
Adresse
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MLSS
Milestone Scientific Inc.
|
0.372 | 33.73M | 8.97M | -5.72M | -2.93M | -0.0701 |
|
ISRG
Intuitive Surgical Inc
|
436.65 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.69 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
208.10 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-09-16 | Eingeleitet | Northland Capital | Market Perform |
| 2018-11-16 | Bestätigt | Maxim Group | Buy |
| 2016-12-23 | Bestätigt | Maxim Group | Buy |
| 2015-12-11 | Eingeleitet | Maxim Group | Buy |
Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower Loss Beats Estimates as Stock Edges LowerOpen Signal Network - Newser
Benchmark reiterates Milestone Scientific stock rating on revenue guidance By Investing.com - Investing.com Nigeria
Benchmark reiterates Milestone Scientific stock rating on revenue guidance - Investing.com
Milestone Scientific (MLSS) price target decreased by 50.00% to 1.02 - MSN
Milestone Scientific, Inc. Common Stock (NY: MLSS - FinancialContent
Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1 - Moomoo
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global Challenges - GuruFocus
Milestone Scientific Earnings Call Signals Cautious Upswing - TipRanks
Milestone Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2026 Earnings Conference - Moomoo
MLSS Projects Strong Revenue Growth Through 2026 - GuruFocus
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations - Investing.com
Milestone Scientific (MLSS) Reports Q1 Revenue Challenges with P - GuruFocus
Full Transcript: Milestone Scientific Q1 2026 Earnings Call - Benzinga
Milestone Scientific stock surges 9% on narrower loss By Investing.com - Investing.com South Africa
Milestone Scientific Q1 revenue steady, operating loss narrows - TradingView
Milestone Scientific stock surges 9% on narrower loss - Investing.com UK
Milestone Scientific Reports Financial Results for First Quarter 2026 - marketscreener.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ... By GuruFocus - Investing.com Canada
Milestone Scientific earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Milestone Scientific (MLSS) trims Q1 2026 loss but flags going concern and NYSE listing risks - Stock Titan
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call - Moomoo
Milestone Scientific will discuss Q1 results and business update May 14 - Stock Titan
Doctors in 7 states begin epidural procedures with CompuFlo - Stock Titan
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption - The Manila Times
Milestone Scientific Inc. 2026 Stock Option Exchange, Incentive Plan, and Performance Sub-Plan Details - Minichart
Milestone Scientific Inc. Files Form 8-K Announcing Change in Auditor – May 2026 SEC Filing - Minichart
Milestone Scientific Restructures Executive Equity Incentive Programs - The Globe and Mail
Milestone Scientific appoints Grassi & Co. as new auditor, dismisses CBIZ CPAs - Investing.com Nigeria
Milestone Scientific approves stock option repricing and new performance-based awards - Investing.com
Milestone Scientific | 8-K: Current report - Moomoo
Auditor switch at Milestone Scientific (NYSE: MLSS) after going concern note - Stock Titan
Milestone Scientific (NYSE: MLSS) reprices options and grants 11.2M performance RSUs - Stock Titan
Milestone Scientific Inc. Files Amendment No. 1 to 2025 Annual Report (Form 10-K/A) with SEC - Minichart
[10-K/A] MILESTONE SCIENTIFIC INC. Amends Annual Report - Stock Titan
MLSS Milestone Scientific beats Q4 2025 loss estimates by 15 percent, shares drop 4.88 percent today.Crowd Breakout Signals - Newser
JPMorgan Active Bond ETF declares monthly distribution of $0.1936 - MSN
Milestone Scientific | D: Filing D - Moomoo
MLSS (Milestone Scientific Inc.) reports narrower Q4 2025 loss than estimates, but shares drop 6.9% in today's trading.Trending Entry Points - Cổng thông tin điện tử tỉnh Tây Ninh
Ballard (BLDP) Business Model Review | Ballard Power Systems Inc. posts 25.3% EPS surprise with narrower lossExpansion Phase - Cổng thông tin điện tử tỉnh Lào Cai
Milestone Scientific Completes Private Placement to Strengthen Finances - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Unusual volume stocks are being observed in Tuesday's session. - ChartMill
Milestone Scientific Inc. Announces $2.15 Million Private Placement to Support Commercial Growth and Strengthen Balance Sheet 12 - Minichart
Finanzdaten der Milestone Scientific Inc.-Aktie (MLSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):